Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B S Yap

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Cancer Research|July 17, 2004
Ser392 phosphorylation regulates the oncogenic function of mutant p53Damian B S Yap, Jung-Kuang Hsieh, Shan Zhong, et al.
Cancer Research|February 1, 1981
Penetration of methylglyoxal bis(guanylhydrazone) into intracerebral tumors in humansM G Rosenblum, D J Stewart, B S Yap, et al.
Cancer Treatment Reports|July 1, 1982
Phase I clinical evaluation of 9,10-anthracenedicarboxyaldehyde[bis(4,5-dihydro-1H-imidazol-2-yl)hydrazone]dihydrochloride (bisantrene)B S Yap, H Y Yap, G R Blumenschein, et al.
American Journal of Clinical Oncology|August 1, 1984
Phase II evaluation of PALA in patients with refractory metastatic sarcomasR Kurzrock, B S Yap, C Plager, et al.
Cancer Treatment Reports|March 1, 1981
Phase II evaluation of AMSA in adult sarcomasB S Yap, C Plager, R S Benjamin, et al.
Cancer|June 15, 1981
A phase II evaluation of methyl CCNU and actinomycin D in the treatment of advanced sarcomas in adultsB S Yap, R S Benjamin, M A Burgess, et al.
Cancer Research|March 1, 1983
Bisantrene, an active new drug in the treatment of metastatic breast cancerH Y Yap, B S Yap, G R Blumenschein, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1983
Clinical pharmacology of 2,5'-diaziridinyl-3,6-biscarboethoxyamino-1,4-benzoquinone (AZQ)K Lu, N Savaraj, B S Yap, et al.
Journal of Surgical Oncology|January 1, 1980
Sarcoma of the stomach: clinicopathologic study of 43 casesA Y Bedikian, N Khankhanian, M Valdivieso, et al.
Cancer Treatment Reports|January 1, 1980
Clinical pharmacology of IMPY by radioimmunoassayK L Fong, D H Ho, B S Yap, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Cancer Research|July 17, 2004
Ser392 phosphorylation regulates the oncogenic function of mutant p53Damian B S Yap, Jung-Kuang Hsieh, Shan Zhong, et al.
Cancer Research|February 1, 1981
Penetration of methylglyoxal bis(guanylhydrazone) into intracerebral tumors in humansM G Rosenblum, D J Stewart, B S Yap, et al.
Cancer Treatment Reports|July 1, 1982
Phase I clinical evaluation of 9,10-anthracenedicarboxyaldehyde[bis(4,5-dihydro-1H-imidazol-2-yl)hydrazone]dihydrochloride (bisantrene)B S Yap, H Y Yap, G R Blumenschein, et al.
American Journal of Clinical Oncology|August 1, 1984
Phase II evaluation of PALA in patients with refractory metastatic sarcomasR Kurzrock, B S Yap, C Plager, et al.
Cancer Treatment Reports|March 1, 1981
Phase II evaluation of AMSA in adult sarcomasB S Yap, C Plager, R S Benjamin, et al.
Cancer|June 15, 1981
A phase II evaluation of methyl CCNU and actinomycin D in the treatment of advanced sarcomas in adultsB S Yap, R S Benjamin, M A Burgess, et al.
Cancer Research|March 1, 1983
Bisantrene, an active new drug in the treatment of metastatic breast cancerH Y Yap, B S Yap, G R Blumenschein, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1983
Clinical pharmacology of 2,5'-diaziridinyl-3,6-biscarboethoxyamino-1,4-benzoquinone (AZQ)K Lu, N Savaraj, B S Yap, et al.
Journal of Surgical Oncology|January 1, 1980
Sarcoma of the stomach: clinicopathologic study of 43 casesA Y Bedikian, N Khankhanian, M Valdivieso, et al.
Cancer Treatment Reports|January 1, 1980
Clinical pharmacology of IMPY by radioimmunoassayK L Fong, D H Ho, B S Yap, et al.
Pageof 4